Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 21 of 32 for:    Acerta Pharma | ( Map: United States )

A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02717624
Recruitment Status : Recruiting
First Posted : March 24, 2016
Last Update Posted : March 28, 2019
Sponsor:
Information provided by (Responsible Party):
Acerta Pharma BV

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2026
Estimated Study Completion Date : May 2026